Fig. 14From: In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein AEvaluation of the functional activity of the anti-PspA1-5c+p antibody. a The complement-mediated killing feature of anti-PspA1-5c+p antibody against pneumococcal strains. b Phagocytosis-mediated killing feature of anti-PspA1-5c+p antibody against pneumococcal strains. The error bar is representative of the mean ± standard deviationBack to article page